UK markets close in 8 hours 25 minutes

Targets Trust XXIV TARGETS 7%INTC (TOI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5701-0.0259 (-4.35%)
At close: 04:00PM EDT
0.5900 +0.02 (+3.49%)
After hours: 04:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.5960
Open0.5800
Bid0.5404 x 100
Ask0.6063 x 100
Day's range0.5650 - 0.6289
52-week range0.3300 - 2.6550
Volume109,969
Avg. volume150,682
Market cap42.437M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference

    CERRITOS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have announced their executives’ participation in multiple panel presentations at the upcoming APG 2024 Spring Conference in San Diego. Chief Medical Officer, Dr. Yale Podnos, will be discussing artificial intelligence and its uses in an oncology practice in the breakout session panel “AI on the Front Lines: Improving Outcomes and Reducing Costs for Complex Patients”. Dr. Danie

  • GlobeNewswire

    The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance

    CERRITOS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2024. Recent Operational Highlights Include: Successfully completed integration of first capitated risk contract direct to a health plan, and launched MSO model to enhance employed clinic locations, in the Florida market, effective

  • GlobeNewswire

    The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

    CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024. About The Oncology Institute, Inc. Founded in 2007, The Oncology Institute, Inc. and its affiliate